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Stroke-rel ated muscle fatigue, particularly of the hip flexors, may interfere with functional mobility and contribute to long-term disability. Many motor tasks that are challenging to stroke survivors require submaximal, symmetric torque production in bilateral hip joints. Decreased power in the paretic hip has been associated with abnormal balance strategies and asymmetries walking kinematics. 1 The weakness of the paretic hip certainly contributes to functional mobility 2Y4 ; specifically, it has been associated with decreased gait velocity. Muscle weakness after stroke has been attributed to muscle atrophy and also impaired voluntary activation because the nervous system is not able to adequately activate the available muscle. 5Y8 Functionally, asymmetric leg kinematics and kinetics have been associated with loss of power (i.e., weakness) and coordination in the paretic hip during walking. 3, 9 The implications of this are that people with stroke have difficulty walking with efficiency in time.
Although weakness is clearly an important factor that contributes to walking impairments, an increased susceptibility to fatigue also likely compounds baseline difficulties in generating hip torque. For example, people with stroke demonstrate alterations in kinematics after short bouts of walking 10Y12 and decreased distance walked during the 6-min walk test compared with healthy controls. 13 Although all of the mechanisms underlying these impairments in walking kinematics and distance walked are not fully understood, neuromuscular fatigue in the paretic hip likely limits motor function by exacerbating strength limitations. Although output is limited at the muscle, factors upstream of the neuromuscular junction (i.e., central) could play a role as well. 14 The contribution of stroke-related neuromuscular fatigue to limitations in functional walking has been largely untested. Neuromuscular fatigue, defined as an exercise-induced reduction in force or power, can be quantified as the reduction in strength in time or as the duration of submaximal sustained tasks. 14, 15 Although stroke patients frequently self-report generalized or systemic fatigue, 16 the examination of stroke-related neuromuscular fatigue has been limited, and no studies have addressed changes in the hip flexor muscles.
Fatigue of the paretic hip flexors, in comparison with other leg muscles, is likely to greatly impact walking function poststroke. Evidence in both human and animal models indicates an important role of hip musculature in the execution of leg movements and the control of the whole leg during walking. 17Y19 Therefore, changes in neuromuscular fatigue of the hip flexors in people after stroke could not only limit walking distance and speed but also interfere with the volitional control of joints distal to the hip. Moreover, because ankle propulsion by the plantar flexors can be significantly compromised after stroke, 9 function of the hip flexors would become even more critical for limb advancement. Therefore, quantitative measures of neuromuscular fatigue of the paretic hip flexors are expected to be associated with walking function in people after stroke.
The purpose of this study, therefore, was to (1) compare hip flexor neuromuscular fatigue using a sustained isometric submaximal contraction 14 of the paretic and nonparetic limbs in patients who had stroke and healthy controls and (2) quantify neuromuscular fatigue of the paretic hip flexors and correlate fatigue metrics with tests of clinical function. We assessed the muscle fatigability of the paretic limb under two different conditions: (1) at 20% of maximal strength of the paretic and (2) at 20% maximal voluntary contraction (MVC) of the nonparetic leg. The absolute torque condition was important because during gait and other bilateral leg tasks, similar torque is required to produce symmetric movement patterns. Therefore, constraining the paretic limb to generate a similar torque as the nonparetic leg during the fatiguing task could potentially expose changes in fatigability that contribute to motor impairment. We also measured maximal force development and variability as additional measures of performance that are affected by fatigue. 14 We hypothesized that (1) the paretic leg would exhibit a briefer time to task failure of the submaximal fatiguing contraction when the absolute target torque was matched with the nonparetic leg's target torque, (2) relative declines in maximal torque production would have stronger relationships with task failure than baseline levels of strength, and (3) motor output variability of the paretic limb during the fatiguing task was expected to correlate more strongly with function compared with the nonparetic leg.
METHODS

Subjects
Thirteen subjects with chronic poststroke hemiparesis were recruited for this study (Table 1) . Chronic stroke is defined here as 6 mos post event. The subjects reported a single cortical stroke incident with subsequent unilateral impairment in sensory and/or motor function. All but one subject (S11) reported injury in the middle cerebral artery territory. Nine of the 13 participants were able to independently ambulate on even surfaces without the use of an orthotic or assistive device. Four subjects, (S1, S3, S4, and S10) used an anklefoot orthosis, and S4 and S10 ambulated with a single-point cane. All subjects reported that they did not use a wheelchair. The participants were excluded if they reported disturbances in vision or neglect, any untreated cardiovascular or orthopedic conditions, osteoporosis, or decubitis ulcerations or if cognitive limitation simpaired their ability to adhere to instructions or provide informed consent. Ten age-matched controls (mean age, 59.4 T 11.2 yrs; five men and five women; mean T SD Physical Activity Questionairre 20 score, 15.86 T 11 MET-hrs/wk) with no history of neurologic injury also participated in the study.
Before fatigue testing, the participants with stroke underwent a clinical evaluation that included passive and active range of motion of bilateral lower limbs, the lower limb Fugl-Meyer test (ability to fractionate lower limb joint movement), the Berg Balance Test (examines both static and dynamic sitting and standing balance), and the 10-m Walk Test (quantifies self-selected walking speed). All evaluations were done by the same licensed physical therapist. Subjects were given 5 mins rest between assessments and at least 15 mins break before the fatigue testing begun. A break period of 15 mins is adequate to recover from peripheral fatigue, and central fatigue resolves within a few minutes. 14 In addition, the criteria to begin testing were the return of blood pressure and heart to resting values.
Seven of the 13 participants with stroke recruited in this study (refer to Table 1 ) also participated in a second testing session on a separate day (at least 1 wk apart). All individuals with stroke were invited to return for a second session, but some participants could not because of scheduling conflicts. Informed consent was obtained from both stroke and control participants, and all experimental procedures were approved by the institutional review board of Marquette University.
Test Apparatus and Set-up
Subjects were assisted onto a height-adjustable therapy plinth and into the robotic test apparatus used to obtain all lower limb torque measurements. The apparatus consisted of two servomotors (Kollmorgen, Northampton, MA) and adjoining leg braces instrumented with torque transducers (S. Himmelstein and Company, Hoffman Estates, IL). For each leg, the head of the greater trochanter was aligned with the axis of rotation of the servomotors. Likewise, the anatomical center of rotation for the ankles and knees were aligned with the center axis of torque transducers within the leg braces. Sagittal plane torques of the hips were measured during MVC measurements and a submaximal fatiguing task. Optical encoders (US Digital, Vancouver, WA) monitored hip position. Throughout all testing protocols, bilateral knees and ankles were held static at 20 degrees flexion and 90 degrees plantarflexion, respectively. Before acquisition, torque signals were lowpass filtered (500 Hz) and then sampled at 1 kHz using a data acquisition card (National Instruments Corp., Austin, TX) and a personal computer. Custom-written LabVIEW (National Instruments Corp.) programs were used to generate a hip trajectory command signal to the servocontroller and acquire all data.
Experimental Design and Protocol
This was an observational case-controlled study. The subjects were familiarized with the robotic device and allowed to practice brief MVC and sustained contraction protocols before experimental testing. All subjects first performed 3Y5 isometric hip flexion MVCs for each leg. The test leg was positioned at 20 degrees hip flexion and the contralateral hip at 0 to 5 degrees hip extension. MVC trials were repeated until peak forces from two of the three trials were less than 5% of each other. One-minute breaks were given between MVCs. Visual feedback was displayed on a computer monitor, and subjects were verbally encouraged throughout each MVC trial. A 10-min rest was given between MVCs and the fatiguing protocol.
Afterward, for the fatiguing protocol, the subjects performed unilateral, sustained submaximal isometric hip flexor muscle contractions. During a given testing session, participants with stroke performed one of the following two protocols:
1. Equal Effort (EE): Subjects performed a submaximal contraction matching 20% of the hip flexion torque MVC of the same leg being tested (e.g., the target torque during the sustained contraction of paretic leg testing was calculated from the paretic leg MVC). For the remainder of this article, we will refer to this torque measurement as the Bipsilateral hip flexion torque.[ 2. Equal Torque (ET): The target torques used during the paretic and nonparetic sustained contractions were 20% of the nonparetic hip flexion MVC (i.e., the paretic target torque was the same as the nonparetic target torque).
Control subjects performed sustained submaximal isometric hip flexor muscle contractions of their dominant leg with target torques that were 20% of the MVC of the leg being tested. Task failure was defined as an inability to maintain the target torque within a T10% window for 4 secs or more or 3 or more failures within a 5-sec continuous window. Subjects were instructed to continue with the task until instructed to stop. Immediately after task failure, subjects performed a final hip flexor MVC. For participants with stroke, after a rest period of 10Y15 mins, the sustained submaximal contraction was repeated for the opposite hip. The order of paretic leg vs. nonparetic hip testing was counterbalanced. Joint torques from the hips were low-pass filtered at 5 Hz, and the torque contribution from gravity of the leg and leg brace were subtracted from the data before further analysis. 21 
Data Analysis Prefatigue MVC Measurements
The hip flexor torque MVC before the fatiguing task (pre-MVC) was the maximum hip torque value across the initial MVC trials. The rate and time-to-peak contraction were calculated for the pre-MVC torque traces. Using the derivative of the MVC torque trace, the rate of contraction was calculated by finding the maximum slope during the time of contraction. The time-to-peak contraction was considered to be the time between the onset of contraction and the peak torque. The onset of the contraction was determined by finding the time of the minimum value of the derivative of the MVC torque trace. The measurements above were made to determine the baseline levels of strength (pre-MVC) necessary to determine the magnitude of fatigue after fatiguing protocol and to assist in the global categorization of motor unit recruitment during an MVC (rate of contraction and time to peak contraction).
Sustained Submaximal Fatiguing Contraction Measurements: Time to Task Failure
Time to task failure (in seconds) was determined by the failure criteria described above (see BExperimental Design and Protocol[). How long an individual can perform a submaximal task is also a metric of fatigue that can be independent of decreases in MVC. 14 In other words, a person can have decreases in MVC but still be able to continue with a submaximal task.
Sustained Submaximal Fatiguing Contraction: Force Fluctuation Measurements
Force fluctuations or variability are a metric of fatigue, and the relative magnitude of the force fluctuations is a metric of steadiness or control that can worsen or decline with fatigue. To determine the relative magnitude of force fluctuations, data from the fatiguing task were divided into ten equal segmentsVthe entire hip flexion torque measurement was split into 10% segments of the total duration. For each 10% segment, fluctuations in motor output were quantified as the coefficient of variation (CV) of the hip flexion torque (standard deviation/mean torque) for the paretic, nonparetic, and control legs.
Postfatigue MVC Measurements
Ultimately, reductions in force following the submaximal contraction demonstrate neuromuscular fatigue. As with the determination of the prefatigue MVC, the maximum hip flexor torque following the fatiguing contraction was the post-MVC value. The ratio of MVC decline (post-MVC/ pre-MVC) was used to normalize for baseline strength for the correlation with time to task failure. In other words, the ratio of MVC decline was used to illustrate that baseline strength was not related with time of task failure. The difference between hip flexor MVC before and after the fatiguing contraction ($MVC) was calculated to relate the absolute magnitude of neuromuscular fatigue with measures of clinical function.
Statistical Analysis
Data are reported as mean T standard deviation. Paired student t tests were used to detect significant differences between the paretic and nonparetic leg mean MVC amplitudes (> = 0.05). Separate one-way analysis of variance for each condition (EE) and (ET) were used to detect significant differences between the mean duration for each submaximal sustained contraction between stroke (paretic and nonparetic legs) and control subjects (> = 0.05). A Tukey post hoc analysis was used for pairwise comparisons. The Pearson product-moment correlation coefficient was used to determine associations between variables. To establish whether associations were present, separate correlations were performed between the time to task failure and the following variables (respectively): prefatigue MVC, ratio of prefatigue MVC (paretic MVC/nonparetic MVC), and ratio of MVC decline. Associations were also done between metrics of fatigue and clinical measures of function. Walking speed (calculated from the 10-m Walk Test) was separately correlated with the following variables: the absolute decline in paretic hip MVC and paretic CV. Likewise, the Berg Balance Score was separately correlated with the following variables: the absolute decline in paretic hip MVC, and paretic CV.
RESULTS
Clinical Assessments
As evaluated by a licensed physical therapist, no participant had range of motion restrictions that prohibited positioning within the testing apparatus. The following subjects exhibited velocitydependent resistance to stretch in one or more muscles of their affected leg: S1, S3, S4, S7, S8, S9, S10, and S12. The mean lower limb Fugl Meyer score was 26 T 5 ( Table 1) . On average, the participants with stroke had a self-selected walking speed of 1.03 T 0.35 m/sec (Table 1 ). Although 6 of the 13 subjects had walking speeds consistent with normative values (1.2 m/sec) 1 , all subjects, by observation, demonstrated asymmetric walking kinematics between the paretic and nonparetic legs, and 7 of the 13 subjects had impaired walking speed. For the Berg Balance Test, the participants with stroke had a mean score of 44 T 10 ( Table 1 ).
Prefatigue MVC Measurements
The mean paretic hip flexor MVC measured before the sustained fatiguing contraction was smaller compared with the nonparetic hip flexor MVC for both protocols ( Table 2 , paired t test, P G 0.05, see Figures 1A , B for single subject example). The paretic leg prefatigue MVC was characterized by a slower rate of torque development (350 N m/sec T 
Time to Task Failure
During the EE protocol, the paretic and nonparetic leg generated a target hip flexor torque of 20% of the ipsilateral MVC. The paretic leg's time to task failure was not significantly different than the nonparetic leg and control leg ( Fig. 2A : paretic, 318 T 204 secs vs. nonparetic, 425 T 511 secs vs. control, 399 T 249 secs, df = 29, F = 0.253, P = 0.779). For the ET protocol, the paretic leg maintained a target torque that was 20% of the nonparetic leg's hip flexor MVC. On average, this resulted in a target torque that was 26% of the paretic leg's MVC (a larger absolute torque magnitude compared with EE). For this sustained contraction, the paretic leg had a significantly shorter time to task failure compared with the nonparetic and control legs ( Fig. 2B : paretic, 126 T 144 secs vs. nonparetic, 382 T 242 secs vs. control, 397 T 249 secs, df = 28, F = 4.865, P = 0.016). For both protocols, the time to task failure of the paretic leg was not associated with either the prefatigue MVC of the paretic leg (EE: r 2 = 0.03, ET: r 2 = 0.12) or the ratio of the paretic and nonparetic leg prefatigue MVC (EE: r 2 = 0.007, ET: r 2 = 0.06). Therefore, the time to failure of the paretic leg was independent of the strength exerted and whether a participant with stroke was weaker compared with the nonparetic side.
Percentage Decline in MVC Measurements
There was a significant decline in MVC hip flexor torque after the fatiguing task for the paretic, nonparetic legs and control subjects ( Table 2) . The mean percentage declines in MVC were not significantly different (i.e. no main effect of test leg group) between protocols ( Table 2 , analysis of variance, df = 49, F = 1.374, P = 0.25).
Ratio of MVC Decline
For both protocols, however, the paretic leg's ratio of MVC decline (see BMETHODS[) was negatively correlated with the paretic leg's time to task failure ( Fig. 3A ; EE, r 2 = 0.42; ET, r 2 = 0.34). Participants with stroke with larger relative declines in MVC force following the sustained contraction had longer time to task failure. In contrast, there was no systematic relationship between the nonparetic and control legs' ratio of MVC decline and respective time to task failure ( Fig. 3B, r 2 e 0.2), which is consistent with previous findings in healthy controls. 22 
Absolute Decline in Force Relates to Walking Speed
The paretic leg's decline in hip flexor MVC torque for the ET protocol was positively correlated with the self-selected walking speed (Fig. 4A , r 2 = 0.4); that is, subjects with faster self-selected walking speeds demonstrated a larger decline in MVC force following the sustained contraction when required to generate the same target torque as the nonparetic leg (ET condition). In contrast, there was no systematic relationship between the decline in paretic leg hip flexor MVC and walking speed for the EE protocol (r 2 G 0.0009) or the nonparetic leg for both protocols (EE: r 2 = 0.01; ET: r 2 = 0.0012). The paretic decline in hip flexor MVC torque for the ET protocol was weakly positively correlated with the Berg Balance score (r 2 = 0.26).
Coefficient of Variation and Measures of Walking Speed and Balance
For both protocols, the mean CV (see BMETHODS[) calculated across the entire trial was not significantly different between the paretic (EE = 0.15 T 0.09; ET = 0.14 T 0.08), nonparetic (EE = 0.12 T 0.05; ET = 0.12 T 0.04), and control (0.13 T 0.09) legs during the fatiguing contraction (EE: df = 29, F = 0.28, P = 0.75; ET: df = 29, F = 0.09, P = 0.91). However, paretic leg CV negatively correlated with comfortable walking speed (Fig. 4B , EE: r 2 = 0.6; ET: r 2 = 0.41, P G 0.05), indicating that slower walkers had greater fluctuations in motor output. In addition, there was an inverse relationship between the paretic leg mean CV and the Berg Balance Test score (Fig. 4C , EE: r 2 = 0.64, P G 0.05; ET: r 2 = 0.35, P G 0.05).
DISCUSSION
The three key findings from this study are (1) the paretic hip flexor muscles have a briefer time to task failure for sustained submaximal contractions compared with the nonparetic leg when absolute target torques were matched, (2) the time to task failure was inversely related to the paretic leg's decline in torque, and (3) the magnitude of force fluctuations of the paretic limb during sustained hip flexion contractions was related to clinical measures of motor impairment and function. In addition to the well-documented findings that the paretic leg has deficits in maximal force production, we also demonstrated deficits of the paretic leg to sustain and control submaximal contractions compared with the nonparetic leg and healthy controls. These latter results are especially relevant because many activities of daily living, such as walking, involve submaximal contractions. This study exposes limitations in the volitional control of sustained, submaximal tasks in the paretic leg, which is lower than to be expected given the small absolute differences in load compared with the nonparetic leg. 23 In healthy adults, many studies support the role of both neural and muscular mechanisms contributing to the inability to maintain a contraction and fatigue. 14, 15, 24 Our study suggests that neural (central) mechanisms that were independent of motivation may play a more dominant role (vs. peripheral mechanisms) in the inability of participants with stroke to maintain a submaximal contraction as compared with the nonparetic and control legs. First, the time to task failure of the paretic leg was inversely correlated with the relative decrement in MVC torque of the paretic leg, and this relationship was not evident for the nonparetic or control legs (Fig. 4 ). This indicates that the ability of the nervous system to sustain a steady drive to the muscle was the primary factor contributing to termination of the contractions; that is, participants with stroke who were not able to sustain the contractions (therefore demonstrated the briefest time to task failure) had the smallest decrements in MVC force. Therefore, participants with stroke varied in their ability to sustain contractions in their paretic leg, but the mechanism was not caused by fatigue within the muscle but rather by an inability to sustain central drive that progressively increases during sustained contractions in healthy individuals. 14, 25 Second, the paretic muscle had a slower neuromuscular contraction compared with the nonparetic leg and control leg. Given that both the rate of peak contraction and the time to peak contraction were significantly slower suggests either a slower rate of recruitment of motor units because of weaker descending commands or a greater proportion of type I fibers within the paretic muscle. If there was a stroke-related change in the proportion of fiber types only, the paretic leg would have exhibited a longer time to task failure, as seen in aging populations. 26 In contrast, the time to task failure of the paretic leg was less for the matched protocol and similar for the same relative intensity compared with the nonparetic leg. Alternatively, a slower rate of recruitment of hip flexor motor units in the paretic limb or an inability to recruit the available motor units would accelerate task failure possibly secondary to less efficient cycling of motor units that can occur during low-force sustained tasks. 27, 28 Taken together, these results suggest that although the nervous system can achieve desired submaximal torques at least during brief contractions after stroke, the strategy by which motor units are recruited may differ compared with the nonparetic leg or healthy controls. Functionally, this may compromise the ability to sustain even a submaximal contraction or the ability of the paretic leg to perform repeated contractions.
Alternatively, participants with stroke may have terminated contractions as a function of motivation. Although we have no direct measurements of motivation, it is unlikely that the lack of motivation contributed to a premature task failure of the paretic leg for several reasons. The subjects received continuous verbal and visual feedback to achieve maximal levels of external motivation. Furthermore, the subjects did not stop the fatiguing contraction; rather, the experimenter terminated the task based on criteria for task failure. Lastly within protocols, the average percentage declines between the paretic and nonparetic leg MVCs were not significantly different, demonstrating that the hip flexor muscles had reached similar physiologic magnitudes of fatigue at task failure. Therefore, that the participants with stroke were not able to sustain the matched torque of the paretic limb for reasons other than lack of motivation.
Our data also demonstrated that the precision of force control in the paretic limb could be associated with larger functional tasks related to walking. We showed that participants with stroke with larger force fluctuations during the fatiguing contraction had more impaired balance and were slower walkers ( Fig. 4) . Although previous studies have shown relationships between function and force fluctuations in healthy and aging adults, 29 there has been limited study of force fluctuations in the stroke population. Loss of precision in sustaining a contraction may be caused by either a loss of larger motor units resulting in a smaller recruitment range and therefore loss of resolution in control of motor output, more variable timing in motor unit activation or disturbance in the cortical visuomotor centers. 22, 29 Muscle fatigue is necessary for effective neuromuscular adaptation, increases in strength and rehabilitation. However, our study is the first to expose that the paretic hip flexor muscles may terminate a submaximal contraction before the muscle has been fully fatigued because of central deficits. Consequently, the inability to achieve larger magnitudes of muscle fatigue may prevent optimal neuromuscular adaptation and recovery in the paretic limb. Stroke patients, however, pose several challenges to achieving neuromuscular fatigue. For example, the magnitude of fatigue in the paretic leg can be influenced by substitution from other muscle groups and compensation from the nonparetic leg. Although compensatory movement strategies permit an individual to complete a motor task, they limit potential recovery by increasing the task's energetics. Furthermore, a loss of activity caused by disability would negatively impact muscle endurance. Understanding the neural substrates that contribute to neuromuscular fatigue during a motor task will facilitate the development of targeted therapeutic interventions that optimize strength training after stroke.
Because time to task failure can be improved with practice 30, 31 or altered with sensory input, training may improve a stroke patient's ability to sustain a contraction and heighten function. Although low-force contractions are the foundation for many activities of daily living, neuromuscular fatigue can vary depending on the types of contractions (i.e., isometric vs. concentric vs. eccentric). Limited by small sample size, future studies will address how the type of contraction affects stroke-related changes in fatigability and whether measures of fatigue from each type of contraction predict function after stroke. In addition, to normalize neuromuscular fatigue after stroke, it will be necessary to conduct experiments that provide information on the structures/pathways responsible for altered patterns of fatigue.
